Fulphila OverviewPegfilgrastim is a PEGylated form of the recombinant human granulocyte colony-stimulating factor (GCSF) analog filgrastim. It serves to stimulate the production of white blood cells (neutrophils). Pegfilgrastim treatment can be used to stimulate bone marrow to produce more neutrophils to fight infection in patients undergoing chemotherapy. Pegfilgrastim has a human half-life of 15 to 80 hours, much longer than the parent filgrastim (3–4 hours).&...
Read more Fulphila Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Pegfilgrastim
Recent Fulphila Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 6mg/0.6ml
- Syringe: 6mg/0.6ml, 6mg/ml
NDC Database Records for Fulphila: (1 result)Sorted by National Drug Code
- 67457-833 Fulphila 6 mg/.6ml Subcutaneous Injection by Mylan Institutional LLC
Other drugs which contain Pegfilgrastim-jmdb or a similar ingredient: (9 results)
- NEULASTA Pegfilgrastim2 discussions
- NYVEPRIA Pegfilgrastim-apgf
- UDENYCA Pegfilgrastim-cbqv
- ZIEXTENZO Pegfilgrastim-bmez